Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Biliary Tract Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02350686
What this trial is testing

XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy

Who this might be right for
Biliary Tract Cancer
Samsung Medical Center 67
Testing effectiveness (Phase 2)Looking for participantsNCT07392541
What this trial is testing

Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Carcinoma
Tongji Hospital 29
Testing effectiveness (Phase 2)Looking for participantsNCT07186842
What this trial is testing

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

Who this might be right for
Advanced Solid Cancers
BioNTech SE 245
Testing effectiveness (Phase 2)Looking for participantsNCT05784688
What this trial is testing

Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorBiliary Tract CancerHead and Neck Squamous Cell Carcinoma+1 more
TiumBio Co., Ltd. 140
Testing effectiveness (Phase 2)Study completedNCT04656249
What this trial is testing

Lenvatinib in Patients With Previously Treated Advanced Biliary Tract Cancer

Who this might be right for
CholangiocarcinomaBiliary Tract CancerTargeted Therapy
Peking Union Medical College Hospital 46
Testing effectiveness (Phase 2)Study completedNCT02346032
What this trial is testing

Phase II Study of Refametinib, a MEK Inhibitor, as Second-line Treatment in Advanced Biliary Tract Adenocarcinoma

Who this might be right for
Biliary Tract Cancer
Samsung Medical Center 4
Testing effectiveness (Phase 2)Study completedNCT04072445
What this trial is testing

Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Gallbladder CarcinomaRefractory Bile Duct Carcinoma+15 more
Mayo Clinic 28
Large-scale testing (Phase 3)Study completedNCT00513539
What this trial is testing

Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder Cancer
University College, London 92
Testing effectiveness (Phase 2)Study completedNCT00634751
What this trial is testing

CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma

Who this might be right for
Pancreatic NeoplasmsBile Duct Neoplasms
University of Wisconsin, Madison 48
Testing effectiveness (Phase 2)Study completedNCT00059865
What this trial is testing

Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Alliance for Clinical Trials in Oncology 68
Early research (Phase 1)Ended earlyNCT02267707
What this trial is testing

Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia

Who this might be right for
Pancreatic NeoplasmsCholestasis
Celgene 1
Early research (Phase 1)Not Yet RecruitingNCT06490198
What this trial is testing

Phase 2 Study: OBI-833/OBI-821 Maintenance for Globo H+ Advanced Biliary Tract Cancer After Gemcitabine/Cisplatin

Who this might be right for
CholangiocarcinomaChemotherapy EffectImmunotherapy
Chang Gung Memorial Hospital 30
Testing effectiveness (Phase 2)UnknownNCT05935579
What this trial is testing

Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract NeoplasmsImmunotherapy
Peking Union Medical College Hospital 40
Early research (Phase 1)UnknownNCT04460456
What this trial is testing

SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors

Who this might be right for
HER2 Positive Solid Tumors
Silverback Therapeutics 58
Large-scale testing (Phase 3)WithdrawnNCT02597465
What this trial is testing

A Randomized, Open-Label, Comparative, Parallel-Group, Multicenter Study of SPARC1507

Who this might be right for
Advanced Biliary Tract Cancer
Sun Pharma Advanced Research Company Limited
Early research (Phase 1)Study completedNCT05858736
What this trial is testing

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

Who this might be right for
MelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+14 more
OncoC4, Inc. 18
Not applicableStudy completedNCT04871321
What this trial is testing

Biomarker Discovery in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerCholangiocarcinomaGallbladder Cancer
CHA University 119
Testing effectiveness (Phase 2)Study completedNCT00747097
What this trial is testing

Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study

Who this might be right for
Time to Progression
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 43
Testing effectiveness (Phase 2)UnknownNCT05781074
What this trial is testing

Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer （CASTLE-08）

Who this might be right for
Advanced Biliary Tract Cancer
Fudan University 25
Large-scale testing (Phase 3)Looking for participantsNCT07265674
What this trial is testing

Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract CancerBiliary Tract Cancer (BTC)
J-Pharma Co., Ltd. 480
Next Page